Premium
Topical corticosteroids versus “wait and see” in the management of solitary mastocytoma in pediatric patients: a long‐term follow‐up
Author(s) -
Patrizi Annalisa,
Tabanelli Michela,
Neri Iria,
Virdi Annalucia
Publication year - 2014
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.12186
Subject(s) - medicine , mastocytoma , surgery , cancer research , tumor cells
Management of patients affected by mastocytoma ( MS ) includes avoiding triggering factors of mast cell degranulation, and administration of symptomatic treatment. We evaluated topical steroid treatment efficiency on the clinical course of MS in a group of patients, comparing the results with another untreated group.We retrospectively evaluated clinical data of 176 patients under 15 years of age, affected by MS and referred to our D ermatological P ediatric S ervice from 1996 to 2010. Ninety‐one of 176 children were treated with topical steroids. Follow‐up was possible in 130 of 176 patients and lasted for 56.3 months on average. We compared 62 treated and 68 untreated patients. There was not statistic difference between the two groups: (i) in the number of healed or partially improved cases; and (ii) in the time of partial regression, although it is quicker with therapy. The time of healing is 16.4 months (on average) with treatment, and 34.7 months (on average, p = 0.001) without any treatment. The resolution of MS is independent of therapy administration, but the time of healing is statistically faster using the local steroids. An appropriate treatment with them is effective and safe, considering the long time needed for spontaneous resolution.